Etoxadrol
Etoxadrol
Etoxadrol (pronounced: et-ox-ad-rol) is a dissociative anesthetic drug that has been found to be an NMDA antagonist. It was developed in the 1970s by Dainippon Pharmaceutical.
Etymology
The term "Etoxadrol" is derived from its chemical structure, specifically its ethoxy group and its adrol group. The prefix "Etox-" comes from "ethoxy", referring to the ethoxy group in its structure, and "-adrol" is a common suffix used in the naming of drugs, particularly those with steroid-like structures.
Pharmacology
Etoxadrol is a dissociative anesthetic, which means it can induce a state of sedation, amnesia, and analgesia. It is an NMDA antagonist, which means it works by blocking the NMDA receptor, a type of glutamate receptor in the brain. This action is thought to be responsible for the drug's anesthetic effects.
History
Etoxadrol was developed in the 1970s by Dainippon Pharmaceutical, a Japanese pharmaceutical company. It was studied for potential medical use, but it has not been widely adopted in clinical practice.
Related Terms
- Dissociative anesthetic: A class of drugs that induce a state of sedation, amnesia, and analgesia.
- NMDA antagonist: A type of drug that blocks the NMDA receptor, a type of glutamate receptor in the brain.
- Dainippon Pharmaceutical: A Japanese pharmaceutical company that developed Etoxadrol.
External links
- Medical encyclopedia article on Etoxadrol
- Wikipedia's article - Etoxadrol
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski